-
公开(公告)号：BRPI0610197B1
公开(公告)日：2021-05-21
申请号：BRPI0610197
申请日：2006-04-28
Applicant: AMGEN INC , UCB PHARMA SA
Inventor： AARON GEORGE WINTERS , ALASTAIR LAWSON , ALISTAIR JAMES HENRY , ANDY POPPLEWELL , CHRISTOPHER PASZTY , DAVID WINKLER , HSIENG SEN LU , JOHN LATHAM , KELLY SUE HOFFMANN , KEVIN GRAHAM , MARTYN KIM ROBINSON , WENYAN SHEN
Abstract: agentes de ligação de esclerostina são descritas composições e métodos relacionados aos epítopos da proteína esclerostina, e agentes de ligação de esclerostina, tais como anticorpos capazes de se ligarem à esclerostina.
-
公开(公告)号：SG10201403400UA
公开(公告)日：2014-10-30
申请号：SG10201403400U
申请日：2006-04-28
Applicant: UCB PHARMA SA , AMGEN INC
Inventor： CHRISTOPHER PASZTY , MARTYN KIM ROBINSON , KEVIN GRAHAM , ALISTAIR JAMES HENRY , KELLY SUE HOFFMAN , JOHN LATHAM , ALASTAIR LAWSON , LU HSIENG SEN , ANDY POPPLEWELL , SHEN WENYAN , DAVID WINKLER , AARON GEORGE WINTERS
Abstract: Compositions and methods relating to epitopes of sclerostin protein, and sclerostin-binding agents, such as antibodies capable of binding to sclerostin, are provided.
-
公开(公告)号：ZA200900349B
公开(公告)日：2009-11-25
申请号：ZA200900349
申请日：2009-01-15
Applicant: AMGEN INC , UCB PHARMA SA
Inventor： KEVIN GRAHAM , JAMES HENRY ALISTAIR , ALASTAIR LAWSON , CHRISTOPHER PASZTY , ROBINSON MARTYN KIM , DAVID WINKLER , HOFFMANN KELLY SUE , JOHN LATHAM , SEN LU HSIENG , ANDY POPPLEWELL , WENYAN SHEN , GEORGE WINTERS AARON
IPC: C07K20100101
-
公开(公告)号：BR122020023315B1
公开(公告)日：2021-06-08
申请号：BR122020023315
申请日：2006-04-28
Applicant: AMGEN INC , UCB PHARMA SA
Inventor： AARON GEORGE WINTERS , ALASTAIR LAWSON , ALISTAIR JAMES HENRY , ANDY POPPLEWELL , CHRISTOPHER PASZTY , DAVID WINKLER , HSIENG SEN LU , JOHN LATHAM , KELLY SUE HOFFMANN , KEVIN GRAHAM , MARTYN KIM ROBINSON , WENYAN SHEN
Abstract: são descritas composições e métodos relacionados aos epítopos da proteína esclerostina, e agentes de ligação de esclerostina, tais como anticorpos capazes de se ligarem à esclerostina.
-
公开(公告)号：BRPI0610197B8
公开(公告)日：2021-05-11
申请号：BRPI0610197
申请日：2006-04-28
Applicant: AMGEN INC , UCB PHARMA SA
Inventor： AARON GEORGE WINTERS , ALASTAIR LAWSON , ALISTAIR JAMES HENRY , ANDY POPPLEWELL , CHRISTOPHER PASZTY , DAVID WINKLER , HSIENG SEN LU , JOHN LATHAM , KELLY SUE HOFFMANN , KEVIN GRAHAM , MARTYN KIM ROBINSON , WENYAN SHEN
Abstract: agentes de ligação de esclerostina são descritas composições e métodos relacionados aos epítopos da proteína esclerostina, e agentes de ligação de esclerostina, tais como anticorpos capazes de se ligarem à esclerostina.
-
Patent Agency Ranking
公开(公告)号：MX358705B
公开(公告)日：2018-08-31
申请号：MX2013011425
申请日：2006-04-28
Applicant: UCB PHARMA SA
Inventor： CHRISTOPHER PASZTY , MARTYN KIM ROBINSON , KEVIN GRAHAM , ALISTAIR JAMES HENRY , KELLY SUE HOFFMAN , JOHN LATHAM , HSIENG SEN LU , ALASTAIR LAWSON , ANDY POPPLEWELL , WENYAN SHEN , DAVID WINKLER , AARON GEORGE WINTERS
Abstract: La presente invención se refiere a composiciones y métodos relacionados a los epitopes de la proteína de esclerostina, y agentes de unión de esclerostina, tales como anticuerpos capaces de unirse a la esclerostina.
-
公开(公告)号：MX348432B
公开(公告)日：2017-06-05
申请号：MX2011003958
申请日：2006-04-28
Applicant: AMGEN INC *
Inventor： JOHN LATHAM , HSIENG SEN LU , CHRISTOPHER PASZTY , MARTYN KIM ROBINSON , ALISTAIR JAMES HENRY , KELLY SUE HOFFMANN , ALASTAIR LAWSON , DAVID WINKLER , AARON GEORGE WINTERS
IPC: C07K16/18 , A61K39/395
Abstract: La presente invención se refiere a un anticuerpo que se une a un epítope de los aminoácidos 138-149 de SEQ ID NO: 1 con la afinidad de unión (Kd) menor o igual a 1 x 10-6 M.
-
公开(公告)号：PT2301961T
公开(公告)日：2017-05-22
申请号：PT10014373
申请日：2006-04-28
Applicant: AMGEN INC
-
公开(公告)号：PT2251351T
公开(公告)日：2017-03-17
申请号：PT10006930
申请日：2006-04-28
Applicant: AMGEN INC
-
公开(公告)号：MY163480A
公开(公告)日：2017-09-15
申请号：MYPI20061977
申请日：2006-04-28
Inventor： CHRISTOPHER PASZTY , WENYAN SHEN , DAVID WINKLER , AARON GEORGE WINTERS , MARTYN KIM ROBINSON , KEVIN GRAHAM , ALISTAIR JAMES HENRY , KELLY SUE HOFFMANN , JOHN LATHAM , ALASTAIR LAWSON , HSIENG SEN LU , ANDY POPPLEWELL
Abstract: COMPOSITIONS AND METHODS RELATING TO EPITOPES OF SCLEROSTIN PROTEIN, AND SCLEROSTIN BINDING AGENTS, SUCH AS ANTIBODIES CAPABLE OF BINDING TO SCLEROSTIN, ARE PROVIDED. FIG 5
-
-
-
-
-
-
-
-
-
Search Results
10
records
(took 0.026 seconds)
